Utilization of the ICF-CY for the classification of therapeutic objectives in the treatment of spasticity in children with cerebral palsy

Nicoletta Battisti, Sandra Bertana, Anna Rosa Colonna, Francesca Pulvirenti, Antonella Cersosimo, Milena Pagnoni

Research output: Contribution to journalArticle

Abstract

• Objective: To identify objectives for treatment of spasticity with botulinum toxin type A (BTX) in children with cerebral palsy (CP), standardize the objectives according to typology, and classify them according to the International Classification of Functioning for Children and Youth (ICF-CY), as well as to analyze treatment goals in relationship to CP clinical type, severity level, and age. • Methods: 188 children were included in the study (mean age, 12 years; 42% female, 58% male). The diplegic type made up 38% of CP cases, the tetraplegic type 35%, and the hemiplegic type 24%. Children were mainly classified in the lowest and highest levels in the Gross Motor Function Classification System (GMFCS 1, 39%; GMFCS 5, 26%). Treatment objectives for individual therapies were discussed, identified, and transcribed in the therapeutic proposals. The objectives were then collected and subjected to an internal audit in order to standardize their denomination. Two trained health care providers expert in the use of the ICF-CY classification mapped the objectives to ICFCY domains and categories. The objectives were then analyzed in relationship to CP clinical type, GMFCS level, and age. • Results: Of the objectives, 88% (246) were in the "Body Functions" domain. In this domain, there were 28 typologies of objectives in 6 categories. Only 12% (32) of the objectives were in the "Activity" domain; there were 11 typologies in 5 categories. In diplegic and hemiplegic patients with mild disability (GMFCS 1), objectives were aimed at improving gait pattern. For quadriplegic patients with severe disability (GMFCS 5), objectives were aimed mainly at controlling deformities and improving health care provision. Objectives concerning pain treatment were proposed principally for patients with diplegic and quadriplegic type CP. • Conclusions: The ICF-CY can be used to categorize treatment objectives proposed for patient improvement in the domains of Body Functions and Activity. Goal setting for BTX injections occurs mainly in the Body Functions domain and aims at finding changes in the gait pattern.

Original languageEnglish
Pages (from-to)506-512
Number of pages7
JournalJournal of Clinical Outcomes Management
Volume21
Issue number11
Publication statusPublished - Nov 1 2014

Fingerprint

Cerebral Palsy
Gait
Therapeutics
Type A Botulinum Toxins
Health Personnel
Delivery of Health Care
Pain
Injections

ASJC Scopus subject areas

  • Medicine(all)
  • Health Policy

Cite this

Utilization of the ICF-CY for the classification of therapeutic objectives in the treatment of spasticity in children with cerebral palsy. / Battisti, Nicoletta; Bertana, Sandra; Colonna, Anna Rosa; Pulvirenti, Francesca; Cersosimo, Antonella; Pagnoni, Milena.

In: Journal of Clinical Outcomes Management, Vol. 21, No. 11, 01.11.2014, p. 506-512.

Research output: Contribution to journalArticle

Battisti, Nicoletta ; Bertana, Sandra ; Colonna, Anna Rosa ; Pulvirenti, Francesca ; Cersosimo, Antonella ; Pagnoni, Milena. / Utilization of the ICF-CY for the classification of therapeutic objectives in the treatment of spasticity in children with cerebral palsy. In: Journal of Clinical Outcomes Management. 2014 ; Vol. 21, No. 11. pp. 506-512.
@article{d094c504a685487d9ff9a01c3724d8dc,
title = "Utilization of the ICF-CY for the classification of therapeutic objectives in the treatment of spasticity in children with cerebral palsy",
abstract = "• Objective: To identify objectives for treatment of spasticity with botulinum toxin type A (BTX) in children with cerebral palsy (CP), standardize the objectives according to typology, and classify them according to the International Classification of Functioning for Children and Youth (ICF-CY), as well as to analyze treatment goals in relationship to CP clinical type, severity level, and age. • Methods: 188 children were included in the study (mean age, 12 years; 42{\%} female, 58{\%} male). The diplegic type made up 38{\%} of CP cases, the tetraplegic type 35{\%}, and the hemiplegic type 24{\%}. Children were mainly classified in the lowest and highest levels in the Gross Motor Function Classification System (GMFCS 1, 39{\%}; GMFCS 5, 26{\%}). Treatment objectives for individual therapies were discussed, identified, and transcribed in the therapeutic proposals. The objectives were then collected and subjected to an internal audit in order to standardize their denomination. Two trained health care providers expert in the use of the ICF-CY classification mapped the objectives to ICFCY domains and categories. The objectives were then analyzed in relationship to CP clinical type, GMFCS level, and age. • Results: Of the objectives, 88{\%} (246) were in the {"}Body Functions{"} domain. In this domain, there were 28 typologies of objectives in 6 categories. Only 12{\%} (32) of the objectives were in the {"}Activity{"} domain; there were 11 typologies in 5 categories. In diplegic and hemiplegic patients with mild disability (GMFCS 1), objectives were aimed at improving gait pattern. For quadriplegic patients with severe disability (GMFCS 5), objectives were aimed mainly at controlling deformities and improving health care provision. Objectives concerning pain treatment were proposed principally for patients with diplegic and quadriplegic type CP. • Conclusions: The ICF-CY can be used to categorize treatment objectives proposed for patient improvement in the domains of Body Functions and Activity. Goal setting for BTX injections occurs mainly in the Body Functions domain and aims at finding changes in the gait pattern.",
author = "Nicoletta Battisti and Sandra Bertana and Colonna, {Anna Rosa} and Francesca Pulvirenti and Antonella Cersosimo and Milena Pagnoni",
year = "2014",
month = "11",
day = "1",
language = "English",
volume = "21",
pages = "506--512",
journal = "Journal of Clinical Outcomes Management",
issn = "1079-6533",
publisher = "Turner White Communications Inc.",
number = "11",

}

TY - JOUR

T1 - Utilization of the ICF-CY for the classification of therapeutic objectives in the treatment of spasticity in children with cerebral palsy

AU - Battisti, Nicoletta

AU - Bertana, Sandra

AU - Colonna, Anna Rosa

AU - Pulvirenti, Francesca

AU - Cersosimo, Antonella

AU - Pagnoni, Milena

PY - 2014/11/1

Y1 - 2014/11/1

N2 - • Objective: To identify objectives for treatment of spasticity with botulinum toxin type A (BTX) in children with cerebral palsy (CP), standardize the objectives according to typology, and classify them according to the International Classification of Functioning for Children and Youth (ICF-CY), as well as to analyze treatment goals in relationship to CP clinical type, severity level, and age. • Methods: 188 children were included in the study (mean age, 12 years; 42% female, 58% male). The diplegic type made up 38% of CP cases, the tetraplegic type 35%, and the hemiplegic type 24%. Children were mainly classified in the lowest and highest levels in the Gross Motor Function Classification System (GMFCS 1, 39%; GMFCS 5, 26%). Treatment objectives for individual therapies were discussed, identified, and transcribed in the therapeutic proposals. The objectives were then collected and subjected to an internal audit in order to standardize their denomination. Two trained health care providers expert in the use of the ICF-CY classification mapped the objectives to ICFCY domains and categories. The objectives were then analyzed in relationship to CP clinical type, GMFCS level, and age. • Results: Of the objectives, 88% (246) were in the "Body Functions" domain. In this domain, there were 28 typologies of objectives in 6 categories. Only 12% (32) of the objectives were in the "Activity" domain; there were 11 typologies in 5 categories. In diplegic and hemiplegic patients with mild disability (GMFCS 1), objectives were aimed at improving gait pattern. For quadriplegic patients with severe disability (GMFCS 5), objectives were aimed mainly at controlling deformities and improving health care provision. Objectives concerning pain treatment were proposed principally for patients with diplegic and quadriplegic type CP. • Conclusions: The ICF-CY can be used to categorize treatment objectives proposed for patient improvement in the domains of Body Functions and Activity. Goal setting for BTX injections occurs mainly in the Body Functions domain and aims at finding changes in the gait pattern.

AB - • Objective: To identify objectives for treatment of spasticity with botulinum toxin type A (BTX) in children with cerebral palsy (CP), standardize the objectives according to typology, and classify them according to the International Classification of Functioning for Children and Youth (ICF-CY), as well as to analyze treatment goals in relationship to CP clinical type, severity level, and age. • Methods: 188 children were included in the study (mean age, 12 years; 42% female, 58% male). The diplegic type made up 38% of CP cases, the tetraplegic type 35%, and the hemiplegic type 24%. Children were mainly classified in the lowest and highest levels in the Gross Motor Function Classification System (GMFCS 1, 39%; GMFCS 5, 26%). Treatment objectives for individual therapies were discussed, identified, and transcribed in the therapeutic proposals. The objectives were then collected and subjected to an internal audit in order to standardize their denomination. Two trained health care providers expert in the use of the ICF-CY classification mapped the objectives to ICFCY domains and categories. The objectives were then analyzed in relationship to CP clinical type, GMFCS level, and age. • Results: Of the objectives, 88% (246) were in the "Body Functions" domain. In this domain, there were 28 typologies of objectives in 6 categories. Only 12% (32) of the objectives were in the "Activity" domain; there were 11 typologies in 5 categories. In diplegic and hemiplegic patients with mild disability (GMFCS 1), objectives were aimed at improving gait pattern. For quadriplegic patients with severe disability (GMFCS 5), objectives were aimed mainly at controlling deformities and improving health care provision. Objectives concerning pain treatment were proposed principally for patients with diplegic and quadriplegic type CP. • Conclusions: The ICF-CY can be used to categorize treatment objectives proposed for patient improvement in the domains of Body Functions and Activity. Goal setting for BTX injections occurs mainly in the Body Functions domain and aims at finding changes in the gait pattern.

UR - http://www.scopus.com/inward/record.url?scp=84911972049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911972049&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84911972049

VL - 21

SP - 506

EP - 512

JO - Journal of Clinical Outcomes Management

JF - Journal of Clinical Outcomes Management

SN - 1079-6533

IS - 11

ER -